KKRC
Kohlberg Kravis Roberts & Co’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $573M | Sell |
13,260,971
-6,000,000
| -31% | -$259M | 11.83% | 3 |
|
|
2025
Q1 | $666M | Sell |
19,260,971
-6,000,000
| -24% | -$207M | 15.04% | 3 |
|
|
2024
Q4 | $693M | Hold |
25,260,971
| – | – | 18.56% | 2 |
|
|
2024
Q3 | $643M | Sell |
25,260,971
-5,800,000
| -19% | -$148M | 8.61% | 3 |
|
|
2024
Q2 | $787M | Hold |
31,060,971
| – | – | 23.6% | 2 |
|
|
2024
Q1 | $960M | Hold |
31,060,971
| – | – | 24.77% | 1 |
|
|
2023
Q4 | $1.25B | Hold |
31,060,971
| – | – | 37.06% | 1 |
|
|
2023
Q3 | $819M | Hold |
31,060,971
| – | – | 28.75% | 1 |
|
|
2023
Q2 | $534M | Hold |
31,060,971
| – | – | 16.54% | 2 |
|
|
2023
Q1 | $515M | Hold |
31,060,971
| – | – | 15.5% | 2 |
|
|
2022
Q4 | $237M | Hold |
31,060,971
| – | – | 7.99% | 4 |
|
|
2022
Q3 | $309M | Hold |
31,060,971
| – | – | 6.2% | 6 |
|
|
2022
Q2 | $282M | Hold |
31,060,971
| – | – | 3.75% | 6 |
|
|
2022
Q1 | $315M | Hold |
31,060,971
| – | – | 2.86% | 7 |
|
|
2021
Q4 | $518M | Hold |
31,060,971
| – | – | 2.84% | 6 |
|
|
2021
Q3 | $1.46B | Hold |
31,060,971
| – | – | 7.26% | 3 |
|
|
2021
Q2 | $1.89B | Hold |
31,060,971
| – | – | 7.68% | 3 |
|
|
2021
Q1 | $1.91B | Sell |
31,060,971
-3,450,000
| -10% | -$213M | 9.64% | 3 |
|
|
2020
Q4 | $2.45B | Hold |
34,510,971
| – | – | 12.45% | 2 |
|
|
2020
Q3 | $1.29B | Hold |
34,510,971
| – | – | 7.4% | 3 |
|
|
2020
Q2 | $1.13B | Sell |
34,510,971
-2,389,690
| -6% | -$77.9M | 6.87% | 3 |
|
|
2020
Q1 | $1.07B | Hold |
36,900,661
| – | – | 6.83% | 3 |
|
|
2019
Q4 | $1.29B | Hold |
36,900,661
| – | – | 6.32% | 3 |
|
|
2019
Q3 | $792M | Hold |
36,900,661
| – | – | 4.46% | 4 |
|
|
2019
Q2 | $995M | Buy |
+36,900,661
| New | +$995M | 12.26% | 3 |
|